ONCOLOGY

17-Gene Genomic Prostate Score Test Results in the Canary Prostate Active Surveillance Study (PASS) Cohort Article

A New Strategy to Control and Eradicate "Undruggable" Oncogenic K-RAS-Driven Pancreatic Cancer: Molecular Insights and Core Principles Learned from Developmental and Evolutionary Biology Review

A prevalidation study for the evaluation of serum biomarkers of Barrett's esophagus and esophageal adenocarcinoma Meeting Abstract

A sequential fractionation workflow with immobilized trypsin paramagnetic beads for expression profiling and identification of serum proteins by LIFT-MALDI-TOF/TOF Meeting Abstract

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS Journal

ANNALS OF ONCOLOGY Journal

ANNALS OF SURGICAL ONCOLOGY Journal

ANNALS OF TRANSLATIONAL MEDICINE Journal

Altered Glycosylation in Prostate Cancer Book Chapter

Apalutamide (APA) plus androgen deprivation therapy (ADT) for metastatic castration-sensitive prostate cancer (mCSPC): Analysis of pain and fatigue in the TITAN study Meeting Abstract

Apalutamide in Patients With Metastatic Castration-Sensitive Prostate Cancer: Final Survival Analysis of the Randomized, Double-Blind, Phase III TITAN Study Article

Applications of imaging mass spectrometry to clinical diagnosis Meeting Abstract

Attacking the most downstream "gatekeeper" signaling module in the oncogenic ERBB/K-RAS signaling pathway to block tumorigenesis and metastasis in human cancer Meeting Abstract

BREAST CANCER RESEARCH Journal

BREAST CANCER RESEARCH AND TREATMENT Journal

BRITISH JOURNAL OF CANCER Journal

CANCER BIOMARKERS Journal

CANCER CAUSES & CONTROL Journal

CANCER CELL INTERNATIONAL Journal

CANCER LETTERS Journal

CANCER MEDICINE Journal

CANCER NURSING Journal

CANCER RESEARCH Journal

CANCERS Journal

CARCINOGENESIS Journal

CDK4/6-MEK Inhibition in MPNSTs Causes Plasma Cell Infiltration, Sensitization to PD-L1 Blockade, and Tumor Regression Article

CLINICAL & EXPERIMENTAL METASTASIS Journal

CLINICAL CANCER RESEARCH Journal

Cancer Journal

Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019 A Systematic Analysis for the Global Burden of Disease Study 2019 Article

Cancer immunotherapy: Identifying cancer testis antigen peptides to enhance antitumor response. Meeting Abstract

Clinical characteristics and outcomes of children with newly diagnosed acute myeloid leukemia and hyperleukocytosis managed with different cytoreductive methods Article

Combining clinicopathological predictors and molecular biomarkers in the oncogenic K-RAS/Ki67/HIF-1 alpha pathway to predict survival in resectable pancreatic cancer Article

Complex Persistent Opioid Dependence-an Opioid-induced Chronic Pain Syndrome Review

Comprehensive Systematic Review of Biomarkers in Metastatic Renal Cell Carcinoma: Predictors, Prognostics, and Therapeutic Monitoring Review

Concomitant use of oral anticoagulants in patients with advanced prostate cancer receiving apalutamide: A post-hoc analysis of TITAN and SPARTAN studies Article

Conquering undruggable oncogenic K-RAS-driven incurable metastatic cancer, and delivering precision medicine at neoadjuvant settings Meeting Abstract

Controlling and conquering incurable metastatic cancer by targeting the major tumor-driving K-RAS/SIAH pathway activation to stratify patients, identify resistant tumor clones, quantify therapy efficacy, forecast tumor relapse, and predict patient survival in the neoadjuvant settings Meeting Abstract

Cystic adenomatoid tumor of the uterus Article

Deep, rapid, and durable prostate-specific antigen decline with apalutamide plus androgen deprivation therapy is associated with longer survival and improved clinical outcomes in TITAN patients with metastatic castration-sensitive prostate cancer Article

Detect early tumor relapse in high-risk breast cancer Meeting Abstract

Detection of rapidly accumulating stress-induced SUMO in prostate cancer cells by a fluorescent SUMO biosensor Article

Developing a new and potent anti-K-RAS strategy by inhibiting SIAH E3 ligase, the most downstream "gatekeeper" in the oncogenic K-RAS signal pathway, to block well-established pancreatic tumor growth Meeting Abstract

Development of a novel antibody-drug conjugate targeting both CEACAM5 and CEACAM6 Meeting Abstract

Diagnostic value of whole-mount crypt analysis of ileal biopsy specimens for the patients with familial small intestinal neuroendocrine tumors Article

Differential lectin capture profiling and identification of serum glycoproteins to detect and monitor prostate cancer Meeting Abstract

Differential plectin isoform expression correlates with aggressive prostate cancer phenotypes Meeting Abstract

Dose Escalation in Stereotactic Body Radiation Therapy for Pancreatic Cancer A Meta-Analysis Article

EBV and Lymphomagenesis Review

EMR documentation of genetics evaluations in patients with ovarian cancer. Meeting Abstract

EXPERIMENTAL CELL RESEARCH Journal

EXPRESSION OF GENES AND PROTEINS SPECIFIC FOR PROSTATE CANCER Review

Effect of Lanreotide Depot/Autogel on Urinary 5-Hydroxyindoleacetic Acid and Plasma Chromogranin A Biomarkers in Nonfunctional Metastatic Enteropancreatic Neuroendocrine Tumors Article

Epigenome-Wide Tumor DNA Methylation Profiling Identifies Novel Prognostic Biomarkers of Metastatic-Lethal Progression in Men Diagnosed with Clinically Localized Prostate Cancer Article

Expressed prostatic secretion (EPS) collection for proteome characterization as an enriched source of prostatic disease biomarkers Meeting Abstract

Expressed prostatic secretions in urine and directly collected prostatic fluids as enriched sources of prostate cancer protein biomarkers Meeting Abstract

FRONTIERS IN ONCOLOGY Journal

Factors associated with adherence to remote patient monitoring for early detection of dehydration risk during radiation treatment for head and neck cancer. Meeting Abstract

Family physicians could help in predicting life expectancy without prostate cancer Letter

Final analysis results from TITAN: A phase 3 study of apalutamide (APA) vs placebo (PBO) in patients (pts) with metastatic castration-sensitive prostate cancer (mCSPC) receiving adrogen deprivation therapy (ADT) Meeting Abstract

Final analysis results from TITAN: A phase III study of apalutamide (APA) versus placebo (PBO) in patients (pts) with metastatic castration-sensitive prostate cancer (mCSPC) receiving androgen deprivation therapy (ADT). Meeting Abstract

First results from TITAN: A phase III double-blind, randomized study of apalutamide (APA) versus placebo (PBO) in patients (pts) with metastatic castration-sensitive prostate cancer (mCSPC) receiving androgen deprivation therapy (ADT). Meeting Abstract

From profiling to function: A role for microRNA miR-888 in promoting prostate cancer progression Meeting Abstract

Fructose-1,6-bisphosphatase Inhibits ERK Activation and Bypasses Gemcitabine Resistance in Pancreatic Cancer by Blocking IQGAP1-MAPK Interaction Article

GLYCOSYLATION AND CANCER Book

Germline mutations in penetrant cancer predisposition genes are rare in men with prostate cancer selecting active surveillance Article

Guidelines for Management of Treatment-Emergent Adverse Events During Rucaparib Treatment of Patients with Metastatic Castration-Resistant Prostate Cancer Article

Gynecologic oncology Journal

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA Journal

Health-related quality of life (HRQoL) and patient-reported outcomes at final analysis of the TITAN study of apalutamide (APA) versus placebo (PBO) in patients (pts) with metastatic castration-sensitive prostate cancer (mCSPC) receiving androgen deprivation therapy (ADT). Meeting Abstract

Health-related quality of life after apalutamide treatment in patients with metastatic castration-sensitive prostate cancer (TITAN): a randomised, placebo-controlled, phase 3 study Article

Herpes Simplex Virus, Human Papillomavirus, and Cervical Cancer: Overview, Relationship, and Treatment Implications Review

Human LINE-1 retrotransposon induces DNA damage and apoptosis in cancer cells Article

Human T-Cell Leukemia Virus I Tax Protein Sensitizes p53-Mutant Cells to DNA Damage Article

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS Journal

Identification of reproducible low mass SELDI protein profiles specific to cisplatin resistance in human ovarian cancer cells Article

Imaging Mass Spectrometry of a Specific Fragment of Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase Kinase Kinase 2 Discriminates Cancer from Uninvolved Prostate Tissue Article

Increased SIAH expression predicts ductal carcinoma in situ (DCIS) progression to invasive carcinoma Article

Inhibit SIAH E3 Ligase, a Downstream Signaling Module Required for the HER2/EGFR/RAS Signal Transduction, To Block Tumorigenesis and Metastasis of Highly Invasive Human Breast Cancers Meeting Abstract

Inhibiting SIAH2 E3 ligase function disrupts focal adhesion and cell junction, inhibits cell mobility and attachment, and blocks tumor invasion and metastasis in oncogenic K-Ras-driven tumors Meeting Abstract

Inhibition of SIAH E3 ligase function leads to increased cell death in metastatic human cancer cells Meeting Abstract

Inhibition of late-stage tumor growth of human pancreatic and triple-negative breast cancer by blocking the most downstream "gatekeeper" signaling module, SIAH E3 ligase, in the oncogenic ERBB/K-RAS signaling pathway Meeting Abstract

Interaction of Retroviral Tax Oncoproteins With Tristetraprolin and Regulation of Tumor Necrosis Factor- Expression Article

Internal Iliac- Enteric Fistula: A Rare Cause of Hemorrhagic Shock. WoS Publication

JAPANESE JOURNAL OF CLINICAL ONCOLOGY Journal

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE Journal

JOURNAL OF CANCER Journal

JOURNAL OF CANCER RESEARCH AND THERAPEUTICS Journal

JOURNAL OF CLINICAL ONCOLOGY Journal

JOURNAL OF SURGICAL ONCOLOGY Journal

Journal of neuro-oncology Journal

LANCET ONCOLOGY Journal

LEUKEMIA Journal

Letter to the Editor: A response to Hruska's case study on molecular breast imaging and the need for true tissue quantification Letter

Long-term outcomes in patients with advanced adrenocortical carcinoma after image-guided locoregional ablation or embolization Article

MOLECULAR CANCER RESEARCH Journal

MYB exhibits racially disparate overexpression and clinicopathologic association in prostate cancer: significance as a predictor of biochemical recurrence Meeting Abstract

Molecular pathology of prostate cancer Article

Normal, benign, preneoplastic, and malignant prostate cells have distinct protein expression profiles resolved by surface enhanced laser desorption/ionization mass spectrometry. Article

Novel Long Noncoding RNA miR205HG Functions as an Esophageal Tumor-Suppressive Hedgehog Inhibitor Article

Novel altered mitochondrial genes in prostate cancer progression Meeting Abstract

ONCOGENE Journal

ONCOLOGIST Journal

ONCOLOGY NURSING FORUM Journal

ONCOLOGY REPORTS Journal

Oncogenic K-RAS activation promotes cell motility, invasion, tumor growth and cancer metastasis via its most downstream signaling module, the SIAH2-ependent proteolytic machinery, in the highly aggressive and metastatic human cancer cells Meeting Abstract

Original Research Apalutamide plus androgen deprivation therapy in clinical subgroups of patients with metastatic castration-sensitive prostate cancer: A subgroup analysis of the randomised clinical TITAN study Article

Overall survival (OS) among Medicare beneficiaries receiving sipuleucel-T (sip-T) versus oral treatment for metastatic castration-resistant prostate cancer (mCRPC) Meeting Abstract

PEDIATRIC BLOOD & CANCER Journal

PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY Journal

PRACTICAL RADIATION ONCOLOGY Journal

PROSTATE CANCER AND PROSTATIC DISEASES Journal

PSMA glycosylation and aggressive prostate cancer progression Meeting Abstract

Patient-Reported Outcomes and Quality of Life with Sunitinib Versus Placebo for Pancreatic Neuroendocrine Tumors: Results From an International Phase III Trial Article

Patient-Reported Symptom Control of Diarrhea and Flushing in Patients with Neuroendocrine Tumors Treated with Lanreotide Depot/Autogel: Results from a Randomized, Placebo-Controlled, Double-Blind and 32-Week Open-Label Study Article

Patient-reported outcomes (PROs) from TITAN: A phase III, randomized, double-blind study of apalutamide (APA) versus placebo (PBO) added to androgen deprivation therapy (ADT) in patients (pts) with metastatic castration-sensitive prostate cancer (mCSPC) Meeting Abstract

Patient-reported outcomes (PROs) in patients (pts) with pancreatic neuroendocrine tumors (NET) receiving sunitinib (SU) in a phase III trial Meeting Abstract

Patterns of Care Among Real-World Patients with Metastatic Neuroendocrine Tumors Article

Performance of the 17-gene genomic prostate score test in men with prostate cancer (PCa) managed with active surveillance (AS): Results from the Canary Prostate Active Surveillance Study (PASS). Meeting Abstract

Persistent EGFR/K-RAS/SIAH pathway activation drives chemo-resistance and early tumor relapse in triple-negative breast cancer Review

Perspectives on Triple-Negative Breast Cancer: Current Treatment Strategies, Unmet Needs, and Potential Targets for Future Therapies Review

Pharmacoproteomic analysis of prechemotherapy and postchemotherapy plasma samples from patients receiving neoadjuvant or adjuvant chemotherapy for breast carcinoma Article

Phase II Clinical Trial of Neoadjuvant and Adjuvant Pembrolizumab in Resectable Local-Regionally for Advanced Head and Neck Squamous Cell Carcinoma Article

Photodynamic therapy for Bowen's Disease (squamous cell carcinoma in situ) current review and update Review

Pneumothorax presentation in endometrial sarcoma patients receiving chemotherapy: A case series Article

Post-prostatectomy PSA slope (ProsVue) in Gleason score >= 7 disease Meeting Abstract

Prognostic impact of post-prostatectomy PSA slope determined with a novel nucleic acid detection immunoassay (NADIA ProsVue) for total PSA Meeting Abstract

Proteomic analysis of SIAH2 E3 ligase complex in oncogenic K-Ras-driven cell transformation and oncogenesis Meeting Abstract

Proteomic analysis of SIAH2 E3 ligase complex in oncogenic K-Ras-driven cell transformation in human cancer Meeting Abstract

Proteomic analysis reveals a network of inflammatory genes in epidermis associated with skin tumor promotion susceptibility in DBA/2 and C57BL/6 mice Meeting Abstract

Proteomic and pathway analyses reveal a network of inflammatory genes associated with differences in skin tumor promotion susceptibility in DBA/2 and C57BL/6 mice Article

Proteomic profiles predict therapy response in patients with squamous cell carcinoma of the head and neck Meeting Abstract

Proton pump inhibitors: the culprit for Barrett's esophagus? Editorial Material

RADIATION ONCOLOGY Journal

RE: Estrogen Plus Progestin and Breast Cancer Incidence and Mortality in the Women's Health Initiative Observational Study Letter

Reinspection of a Clinical Proteomics Tumor Analysis Consortium (CPTAC) Dataset with Cloud Computing Reveals Abundant Post-Translational Modifications and Protein Sequence Variants Article

SIAH-dependent proteolysis modulates focal adhesion, cell junction, and cell motility in response to oncogenic K-RAS activation in human cancer cells Meeting Abstract

Serum Protein Profiles to Identify Head and Neck Cancer Article

Serum levels of an isoform of apolipoprotein A-II as a potential marker for prostate cancer Article

Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men. Article

Sunitinib in pancreatic neuroendocrine tumors: updated progression-free survival and final overall survival from a phase III randomized study Article

TARGETED ONCOLOGY Journal

TITAN, a phase 3 study of apalutamide (APA) versus placebo (PBO) in patients (pts) with metastatic castration-sensitive prostate cancer (mCSPC) receiving androgen deprivation therapy (ADT) Meeting Abstract

Tailoring Intensity of Active Surveillance for Low-Risk Prostate Cancer Based on Individualized Prediction of Risk Stability Article

Targeting SIAH2-dependent proteolysis downstream of the HER2/EGFR/RAS signaling pathway to inhibit tumorigenesis and metastasis of highly invasive human breast cancer Meeting Abstract

Technical Feasibility of Tissue Microarray (TMA) Analysis of Tumor-Associated Immune Response in Prostate Cancer Article

The Journal of pathology Journal

The SIAH2-SMAD2/3/4 antagonism downstream of the K-RAS and TGF beta signaling pathways during tumor initiation, progression and metastasis of human cancer Meeting Abstract

The critical role of seven-in-absentia (SINA) family E3 ligases in normal development and oncogenic K-RAS-driven human cancer Meeting Abstract

The effect of prior docetaxel (DOC) treatment on efficacy and safety of apalutamide (APA) plus androgen deprivation therapy (ADT) in patients (pts) with metastatic castration-sensitive prostate cancer (mCSPC) from TITAN. Meeting Abstract

The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019 Article

Therapeutic Efficacy of Aldoxorubicin in an Intracranial Xenograft Mouse Model of Human Glioblastoma Article

Three versus four cycles of neoadjuvant gemcitabine cisplatin for muscle invasive bladder cancer (MIBC). Meeting Abstract

Tight junction proteins: From barrier to tumorigenesis Review

Time to second progression (PFS2) in patients (pts) from TITAN with metastatic castration-sensitive prostate cancer (mCSPC) by first subsequent therapy (hormonal vs. taxane) Meeting Abstract

Toxicity, Response Rates and Survival Outcomes of Induction Cisplatin and Irinotecan Followed by Concurrent Cisplatin, Irinotecan and Radiotherapy for Locally Advanced Esophageal Cancer Article

Treatment in the absence of disease reclassification among men on active surveillance for prostate cancer Article

Treatment-related complications of radiation therapy after radical prostatectomy: comparative effectiveness of intensity-modulated versus conformal radiation therapy Article

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS Journal

Underreporting of race in genomic sequencing studies increases cancer health information disparities Meeting Abstract

Updated overall survival (OS) and progression-free survival (PFS) by blinded independent central review (BICR) of sunitinib (SU) versus placebo (PBO) for patients (Pts) with advanced unresectable pancreatic neuroendocrine tumors (NET) Meeting Abstract

What intensivists need to know about hemophagocytic syndrome: an underrecognized cause of death in adult intensive care units. WoS Publication

Researchers@EVMS

ONCOLOGY Web of Science Category

Overview

broader concept

Research

category